Alicia C. Lenzen, MD

Clinical and Community Trials

Biography

  • Attending Physician, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Program Director, Pediatric Neuro-Oncology Fellowship, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Rory David Deutsch Malignant Brain Tumor Research Scholar, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Assistant Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

  • Fellowship in Pediatric Neuro-Oncology, Ann & Robert H. Lurie Children's Hospital of Chicago 2018-2019
  • Fellowship in Pediatric Hematology Oncology, McGaw Medical Center of Northwestern University 2015-2018
  • Residency in Pediatrics, Advocate Christ Hospital Medical Center 2011-2014
  • Warren Alpert Medical School Of Brown University 2011

Clinical Studies

Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma

Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

Recruiting

Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery

See All Studies

Publications

Sep. 08, 2023

Using IT to Improve Outcomes for Children Living With Cancer (SyMon-SAYS): Protocol for a Single-Institution Waitlist Randomized Controlled Trial.

Aug. 01, 2023

Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).

Jul. 18, 2023

Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review.

See all publications